Press Releases
Study shows that in HER2 positive early breast cancer 6 months treatment with Herceptin is as good as 12 months for preventing cancer return
A new study co-led by the University of Warwick Clinical Trials Unit has shown that shortening the duration of a therapy for breast cancer patients does not increase the risk of their cancer returning.
Novel anti-cancer drug delivery system being presented in Parliament by Warwick student
Sean Ellacott, 25, a third year PhD student at the University of Warwick, , is attending Parliament to present his chemistry research about the interaction of self-assembling nanotubes with biological models, which are currently being considered for the delivery of anticancer drugs, to a range of politicians and a panel of expert judges, as part of STEM for BRITAIN on Wednesday 13 March.
Simply shining light on dinosaur metal compound kills cancer cells
A new compound based on Iridium, a rare metal which landed in the Gulf of Mexico 66 M years ago, hooked onto albumin, a protein in blood, can attack the nucleus of cancerous cells when switched on by light, University of Warwick researchers have found.